The Necker–Enfants Malades Hospital is a French teaching hospital in the 15th arrondissement of Paris. It is a hospital of the Assistance Publique – Hôpitaux de Paris group and is affiliated to the University of Paris Descartes.

During the past decade, Hopital Necker, Universite Paris Descartes conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Necker, Universite Paris Descartes" are "Alport Syndrome" (2 trials), "Autosomal Dominant Polycystic Kidney" (2 trials), "ADPKD" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "Hopital Necker, Universite Paris Descartes" in a lesser frequency.

Most popular intervention types in "Hopital Necker, Universite Paris Descartes" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bardoxolone Methyl" (1 trials), "Bardoxolone methyl" (1 trials), "Bardoxolone methyl oral capsule" (1 trials), "Placebo Oral Capsule" (1 trials) and "Placebo oral capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Necker, Universite Paris Descartes" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Necker, Universite Paris Descartes". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Necker, Universite Paris Descartes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Necker, Universite Paris Descartes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".